---
title: "Disrupting Scientific Friction: How Ome Ogbru Uses AI to Free Real Science"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285603607.md"
description: "In the field of life sciences, innovation is crucial, but many companies continue to rely on inefficient workflows and manual tasks that consume valuable time. AINGENS CEO and founder Ome Ogbru, PharmD, highlights that the issue lies not in a lack of intelligence, but rather in the ineffective processes that are in place. These inefficiencies hinder progress and hinder experts from performing efficiently."
datetime: "2026-05-07T19:13:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285603607.md)
  - [en](https://longbridge.com/en/news/285603607.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285603607.md)
generator: "portal-rs"
---

# Disrupting Scientific Friction: How Ome Ogbru Uses AI to Free Real Science

In the field of life sciences, innovation is crucial, but many companies continue to rely on inefficient workflows and manual tasks that consume valuable time. AINGENS CEO and founder Ome Ogbru, PharmD, highlights that the issue lies not in a lack of intelligence, but rather in the ineffective processes that are in place. These inefficiencies hinder progress and hinder experts from performing efficiently.

### Related Stocks

- [AGEN.US](https://longbridge.com/en/quote/AGEN.US.md)
- [000863.CN](https://longbridge.com/en/quote/000863.CN.md)
- [INGN.US](https://longbridge.com/en/quote/INGN.US.md)
- [159883.CN](https://longbridge.com/en/quote/159883.CN.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [XHS.US](https://longbridge.com/en/quote/XHS.US.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [516610.CN](https://longbridge.com/en/quote/516610.CN.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [562600.CN](https://longbridge.com/en/quote/562600.CN.md)

## Related News & Research

- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [Agenus posts investor deck spotlighting botensilimab-balstilimab neoadjuvant program in MSS colon cancer](https://longbridge.com/en/news/296536017.md)
- [Agenus extends $24.75 million loan maturity to Nov. 2029 in Ocean 1181 amendment](https://longbridge.com/en/news/296267258.md)
- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [Dimensional Fund Advisors LP Reduces Position in Inogen, Inc $INGN](https://longbridge.com/en/news/295760298.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**